Article
COVID-19 First and Delta Waves in Relation to ACEI, ARB, Influenza Vaccination, and Comorbidity in a North Metropolitan Barcelona Health Consortium
2022-03-02
Abstract excerpt
BACKGROUND Some authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vaccination. The impact of these variables on the evolution of hospitalized patients, focusing in the first wave and the Delta wave, is explored. METHODS COVID-19 hospi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a535cac2-4769-5b29-9ef9-56334a7bf9da
- DOI
- 10.21203/rs.3.rs-1272080/v1
